Their detailed laboratory recommendations provided a robust framework for the precise and reproducible RT-qPCR based analysis of e1a2 BCR-ABL1 transcript and will facilitate valid comparison of MRD results between clinical trials for Ph+ ALL. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.